Bioventus Inc. (BVS) Form 8-K Material Events
Bioventus Inc. (BVS) is a publicly traded company on the Nasdaq, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BVS
CIK: 1665988
Exchange: Nasdaq
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerDewayne Southern
Audit LocationRaleigh, North Carolina, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-05 | 2026-06-27 | 10-Q | 0001665988-26-000042 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001665988-26-000041 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002205 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001382909-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001017832-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001221375-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001198330-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001222362-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001904156-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001760737-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001106508-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001679773-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001627985-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-03 | 8-K | 0001665988-26-000035 | View SEC Doc Filr Page |
| SD | 2026-05-29 | — | SD | 0001665988-26-000031 | View SEC Doc Filr Page |
| 8-K | 2026-05-21 | 2026-05-21 | 8-K | 0001665988-26-000029 | View SEC Doc Filr Page |
| 10-Q | 2026-05-06 | 2026-03-28 | 10-Q | 0001665988-26-000027 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-06 | 8-K | 0001665988-26-000026 | View SEC Doc Filr Page |
| ARS | 2026-04-22 | 2025-12-31 | ARS | 0001665988-26-000017 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-22 | — | DEFA14A | 0001665988-26-000015 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-22 | 2025-12-31 | DEF 14A | 0001665988-26-000014 | View SEC Doc Filr Page |
| 4/A | 2026-04-14 | 2021-04-01 | FORM 4/A | 0001679773-26-000004 | View SEC Doc Filr Page |
| 4/A | 2026-04-14 | 2021-02-11 | FORM 4/A | 0001679773-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-04-14 | 2026-04-10 | FORM 4 | 0001914936-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-04-14 | 2026-04-10 | FORM 4 | 0001204391-26-000006 | View SEC Doc Filr Page |